Abstract
BackgroundACQUIRE was a Ph IIIb study demonstrating comparability of SC and IV abatacept (ABA) over a 6-mth DB period. At 6 mths, all patients (pts) entered an open-label (OL) period...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have